Funding & Deals
Sep 25, 2026 · 1 min read · 9,082 views
Iambic releases next version of its Enchant model, signs deal with AbbVie
M
Maya Chen
Editorial · Sep 25, 2026
Iambic launched Enchant v3, a 41B parameter AI model, and signed an R&D deal with AbbVie for small molecules in immunology, neuroscience, and oncology
← Previous
Celldex falls on safety concern, even as chronic hives drug succeeds in Phase 3 trials
Next →
Eli Lilly invests in startup Abridge for clinical trial recruitment
